Show items per page
Elements: 49
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
Viral diversity based on next-generation sequencing of HIV-1 provides precise estimates of infection recency and time since infection Carlisle, Louisa A; Turk, Teja; Kusejko, Katharina; Metzner, Karin J; ... Kouyos, Roger D 2019
add to browser selection
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; ... Calmy, Alexandra 2014
add to browser selection
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs Oberle, Corinna S; Joos, Beda; Rusert, Peter; Campbell, Nottania K; ... Günthard, Huldrych F 2016
add to browser selection
The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort Study Glass, Tracy R; Günthard, Huldrych F; Calmy, Alexandra; Bernasconi, Enos; ... Furrer, Hansjakob 2021
add to browser selection
The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the swiss mother and child HIV cohort study Compagno, Francesca; Naegele, Klaudia; Kahlert, Christian R; Hösli, Irene; ... Hirsch, Hans H 2019
add to browser selection
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients Beerenwinkel, Niko; Montazeri, Hesam; Schuhmacher, Heike; Knupfer, Patrick; ... Calmy, Alexandra 2013
add to browser selection
The cumulative impact of harm reduction on the swiss HIV epidemic: cohort study, mathematical model, and phylogenetic analysis Marzel, Alex; Kusejko, Katharina; Weber, Rainer; Bruggmann, Philip; ... Kouyos, Roger D 2018
add to browser selection
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link Nguyen, Huyen Tran; Thorball, Christian Wandell; Fellay, Jacques; Böni, Jürg; ... Kouyos, Roger D 2021
add to browser selection
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study Scherrer, Alexandra U; Yang, Wan-Lin; Kouyos, Roger D; Böni, Jürg; ... Günthard, Huldrych F 2016
add to browser selection
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort Study Fehr, Jan; Glass, Tracy R; Louvel, Séverine; Hamy, François; ... Klimkait, Thomas 2011
add to browser selection
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics Kühnert, Denise; Kouyos, Roger; Shirreff, George; Pečerska, Jūlija; ... Bonhoeffer, Sebastian 2018
add to browser selection
Phylogenetic cluster analysis identifies virological and behavioral drivers of HIV transmission in MSM. Bachmann, Nadine; Kusejko, Katharina; Nguyen, Huyen; Chaudron, Sandra E; ... Kouyos, Roger D 2020
add to browser selection
Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds Yang, Wan-Lin; Kouyos, Roger D.; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F. 2015
add to browser selection
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection Metzner, Karin J; Scherrer, Alexandra U; Preiswerk, Benjamin; Joos, Beda; ... Günthard, Huldrych F 2013
add to browser selection
Nouveautés dans le diagnostic du VIH Hampel, Benjamin; Böni, Jürg; Vernazza, Pietro; Lehner, Andreas; ... Fehr, Jan S. 2021
add to browser selection
Non-inferiority of simplified dolutegravir monotherapy compared to continued combination antiretroviral therapy that was initiated during primary HIV infection: a randomized, controlled, multi-site, open-label, non-inferiority trial Braun, Dominique L; Turk, Teja; Tschumi, Fabian; Grube, Christina; ... Günthard, Huldrych F 2019
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens Scherrer, Alexandra U; Böni, Jürg; Yerly Ferrillo, Sabine; Klimkait, Thomas; ... Günthard, Huldrych F 2012
add to browser selection
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients Metzner, Karin J; Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2014
<< previous | 1 | 2 | 3 |